Combination therapy with a CD4-CDR3 peptide analog and cyclosporin A to prevent graft-vs-host disease in a MHC-haploidentical bone marrow transplantation model.

Source:http://linkedlifedata.com/resource/pubmed/id/9434804

Download in:

View as

General Info

PMID
9434804